Active Ingredient
Xylazine (as hydrochloride) as an injectable solution.
Indications
Cattle
For sedation, muscle relaxation and analgesia in minor surgical procedures.
In combination with other substances for anesthesia.
Horses
For sedation and muscle relaxation.
In combination with other substances for analgesia and anesthesia.
Dogs and Cats
For sedation. In combination with other substances for analgesia, anesthesia and muscle relaxation.
Dosage and Administration Route
Intravenous route
| Dose level | Xylazine (mg/kg b.w.) | Xylamidor (ml/100 kg b.w.) | Xylamidor (ml/500 kg b.w.) |
| I | 0.016–0.024 | 0.08–0.12 | 0.4–0.6 |
| II | 0.034–0.05 | 0.18–0.25 | 0.85–1.25 |
| III | 0.066–0.10 | 0.33–0.5 | 1.65–2.5 |
Intramuscular route
| Dose level | Xylazine (mg/kg b.w.) | Xylamidor (ml/100 kg b.w.) | Xylamidor (ml/500 kg b.w.) |
| I | 0.05 | 0.25 | 1.25 |
| II | 0.1 | 0.5 | 2.5 |
| III | 0.2 | 1.0 | 5.0 |
| IV | 0.3 | 1.5 | 7.5 |
Horses
For sedation:
- 0.6–1.0 mg xylazine/kg b.w. intravenously (equivalent to 3–5 ml per 100 kg b.w.).
For anesthesia induction in combination with ketamine:
- 1 mg xylazine/kg b.w. intravenously (equivalent to 5 ml per 100 kg b.w.), followed by 2 mg ketamine/kg b.w. intravenously after deep sedation onset.
Dogs
For sedation:
- 1 mg xylazine/kg b.w. intravenously (equivalent to 0.5 ml per 10 kg b.w.).
- 1 to 3 mg xylazine/kg b.w. intramuscularly (equivalent to 0.5–1.5 ml per 10 kg b.w.).
For anesthesia induction with ketamine:
- 2 mg xylazine/kg b.w. intramuscularly (1 ml per 10 kg b.w.) and 610 mg ketamine/kg b.w. intramuscularly.
Cats
For sedation:
- 2 mg xylazine/kg b.w. intramuscularly (0.1 ml/kg b.w.).
- 2 to 4 mg xylazine/kg b.w. subcutaneously (0.1–0.2 ml/kg b.w.).
For anesthesia induction in combination with ketamine:
2 mg xylazine/kg b.w. intramuscularly (0.1 ml/kg b.w.) and 5–15 mg ketamine/kg b.w. intramuscularly.
Withdrawal Period
Milk cattle: 0 hours
Presentations
25 ml vial
Registration number 4217 ESP